APA (7th ed.) Citation

RA, M., EM, A., HF, A., WM, F., AA, B., MM, A., . . . AM, A. (2026). Calcium Carbonate-Stabilized Nano-Caffeine Emulsion Attenuates Diabetic Cardiomyopathy via Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Pathways in Type 2 Diabetic Rats with HPLC-Quantified Cardiac Caffeine Levels. International journal of nanomedicine, 21, 573949. https://doi.org/10.2147/IJN.S573949

Chicago Style (17th ed.) Citation

RA, Mansouri, Aboubakr EM, Alshaibi HF, Fouda WM, Banjabi AA, Al-Bazi MM, Mohammed HA, and Ahmed AM. "Calcium Carbonate-Stabilized Nano-Caffeine Emulsion Attenuates Diabetic Cardiomyopathy via Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Pathways in Type 2 Diabetic Rats with HPLC-Quantified Cardiac Caffeine Levels." International Journal of Nanomedicine 21 (2026): 573949. https://doi.org/10.2147/IJN.S573949.

MLA (9th ed.) Citation

RA, Mansouri, et al. "Calcium Carbonate-Stabilized Nano-Caffeine Emulsion Attenuates Diabetic Cardiomyopathy via Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Pathways in Type 2 Diabetic Rats with HPLC-Quantified Cardiac Caffeine Levels." International Journal of Nanomedicine, vol. 21, 2026, p. 573949, https://doi.org/10.2147/IJN.S573949.